Back

End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial.

29 August 2022 (08:15 - 08:40)
Organised by:
Congress Presentation Part of: Coronary artery disease - Prevention Prevention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mrs Amber Van Broekhoven

Radboud University Nijmegen, Nijmegen (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Ordinal scoring of coronary artery calcification in low dose computed tomography is predictive factor of all-cause death and cardiovascular events.
Mr P. Kasprzyk (Gdansk, PL)
Abstract Slides
Presentation thumbnail
Long-term risk factor control after acute coronary syndrome; results from the swedish primary care cardiovascular database
Doctor S. Bentzel (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Statin therapy intensity and physical activity after acute coronary syndrome
Mr A. Boudon (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Cardiovascular disease risk in males and females with new onset diabetes: a population-based study in universal health care setting
Professor P. Kaul (Edmonton, CA)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease - Prevention

The Event

Event poster

ESC Congress 2022

29 August 2022 08:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources